Clinical trial · Interventional
Reducing Skin Cancer Risk in Childhood Cancer Survivors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this study is to determine the impact of a 12-month patient activation and education intervention on skin cancer early detection practices among childhood cancer survivors treated with radiation. This randomized controlled trial uses a three-group design. Our specific aims are to: (1) Determine the impact of a Patient Activation and Education intervention with and without physician activation and teledermatology on skin cancer early detection practices, (2) Determine the impact of the intervention on time to diagnosis, and (3) Estimate the cost and cost-effectiveness of the intervention as a secondary outcome.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Skin Neoplasms | Skin Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| PAE physician activation, plus teledermoscopy (PAE +MD +TD) | Behavioral | — | UNRESOLVED |
| PAE plus physician activation (PAE + MD) | Behavioral | — | UNRESOLVED |
| Patient activation and education (PAE) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Patient activation and education
- description
- Patient activation and education (PAE)
- interventionNames
- Behavioral: Patient activation and education (PAE)
- type
- EXPERIMENTAL
- label
- PAE plus physician activation
- description
- PAE plus physician activation (PAE + MD)
- interventionNames
- Behavioral: PAE plus physician activation (PAE + MD)
- type
- EXPERIMENTAL
- label
- PAE, MD, plus teledermoscopy
- description
- PAE physician activation, plus teledermoscopy (PAE +MD +TD)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * treated with radiation for a childhood cancer * have a regular healthcare provider whom he/she has seen in the previous 2 years, or plans to see in the next year * have a phone that can receive text messages * have access to a dermlite compatible smartphone or tablet Exclusion Criteria: * personal history of a skin cancer diagnosis
References
Publications (2)
- DERIVEDGeller AC, Coroiu A, Keske RR, Haneuse S, Davine JA, Emmons KM, Daniel CL, Gibson TM, McDonald AJ, Robison LL, Mertens AC, Elkin EB, Marghoob A, Armstrong GT. Advancing Survivors Knowledge (ASK Study) of Skin Cancer Surveillance After Childhood Cancer: A Randomized Controlled Trial in the Childhood Cancer Survivor Study. J Clin Oncol. 2023 Apr 20;41(12):2269-2280. doi: 10.1200/JCO.22.00408. Epub 2023 Jan 9. PMID 36623247
- DERIVEDDaniel CL, Armstrong GT, Keske RR, Davine JA, McDonald AJ, Sprunck-Harrild KM, Coleman C, Haneuse SJ, Mertens AC, Emmons KM, Marghoob AA, Elkin EB, Dusza SW, Robison LL, Geller AC. Advancing Survivors' Knowledge (ASK) about skin cancer study: study protocol for a randomized controlled trial. Trials. 2015 Mar 24;16:109. doi: 10.1186/s13063-015-0637-x. PMID 25873142